An Intrinsically Disordered Peptide Facilitates Non-Endosomal Cell Entry
Many cell‐penetrating peptides (CPPs) fold at cell surfaces, adopting α‐ or β‐structure that enable their intracellular transport. However, the same structural folds that facilitate cellular entry can also elicit potent membrane‐lytic activity, limiting their use in delivery applications. Further, a...
Saved in:
Published in | Angewandte Chemie Vol. 128; no. 10; pp. 3430 - 3433 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English German |
Published |
Weinheim
Blackwell Publishing Ltd
01.03.2016
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Many cell‐penetrating peptides (CPPs) fold at cell surfaces, adopting α‐ or β‐structure that enable their intracellular transport. However, the same structural folds that facilitate cellular entry can also elicit potent membrane‐lytic activity, limiting their use in delivery applications. Further, a distinct CPP can enter cells through many mechanisms, often leading to endosomal entrapment. Herein, we describe an intrinsically disordered peptide (CLIP6) that exclusively employs non‐endosomal mechanisms to cross cellular membranes, while being remarkably biocompatible and serum‐stable. We show that a single anionic glutamate residue is responsible for maintaining the disordered bioactive state of the peptide, defines its mechanism of cellular entry, and is central to its biocompatibility. CLIP6 can deliver membrane‐impermeable cargo directly to the cytoplasm of cells, suggesting its broad utility for delivery of drug candidates limited by poor cell permeability and endosomal degradation.
Fehlgeordnete Verhältnisse: Das intrinsisch fehlgeordnete Peptid CLIP6 vermittelt den Eintritt in Zellen durch ein nichtendosomales physikalisches Überwinden der Membran. Diese Aktivität ist eine Folge des nichtstrukturierten Zustands; sie erleichtert den Transport ansonsten nicht membranpermeierender Substanzen in das Zellinnere. |
---|---|
Bibliography: | National Cancer Institute National Institutes of Health istex:4F2635465BE8ED3C4219346524F29EF7B4174552 ark:/67375/WNG-S3WS8B2D-R ArticleID:ANGE201510518 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0044-8249 1521-3757 |
DOI: | 10.1002/ange.201510518 |